Jazz Pharmaceuticals (JAZZ) R&D In Process (2016 - 2025)
Historic R&D In Process for Jazz Pharmaceuticals (JAZZ) over the last 10 years, with Q3 2025 value amounting to $42.5 million.
- Jazz Pharmaceuticals' R&D In Process changed N/A to $42.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $947.9 million, marking a year-over-year increase of 328522.14%. This contributed to the annual value of $10.0 million for FY2024, which is 4736.84% down from last year.
- Latest data reveals that Jazz Pharmaceuticals reported R&D In Process of $42.5 million as of Q3 2025.
- In the past 5 years, Jazz Pharmaceuticals' R&D In Process ranged from a high of $905.4 million in Q2 2025 and a low of $1.0 million during Q1 2023
- Its 4-year average for R&D In Process is $203.0 million, with a median of $42.5 million in 2025.
- In the last 5 years, Jazz Pharmaceuticals' R&D In Process plummeted by 9520.0% in 2023 and then soared by 90000.0% in 2024.
- Over the past 4 years, Jazz Pharmaceuticals' R&D In Process (Quarter) stood at $375.0 million in 2022, then tumbled by 95.2% to $18.0 million in 2023, then plummeted by 44.44% to $10.0 million in 2024, then skyrocketed by 325.0% to $42.5 million in 2025.
- Its R&D In Process was $42.5 million in Q3 2025, compared to $905.4 million in Q2 2025 and $10.0 million in Q1 2024.